SCHEMBL928902

SCHEMBL928902

C=C(C(=O)O)c1ccccc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.60
HPGD P15428 7/20 0.60
ALDH1A1 P00352 5/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
CA12 O43570 1/20 0.60
CA1 P00915 1/20 0.60
CA2 P00918 1/20 0.60
HMGB1 P09429 1/20 0.60
CA4 P22748 1/20 0.60
CA6 P23280 1/20 0.60
CA7 P43166 1/20 0.60
CA9 Q16790 1/20 0.60
NAPRT Q6XQN6 1/20 0.60
CA14 Q9ULX7 1/20 0.60
HSD17B10 Q99714 4/20 0.52
MAPT P10636 3/20 0.52
TSHR P16473 3/20 0.52
LMNA P02545 3/20 0.48
ALOX15 P16050 2/20 0.48
TP53 P04637 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30231535 1.00 KDM4E (0.60) KDM4EHPGDALDH1A1SMN1; SMN2CA12
SCHEMBL11123891 0.85 ALDH1A1 (0.52) KDM4EHPGDALDH1A1SMN1; SMN2CA12
SCHEMBL6272624 0.83 TERT (0.46) KDM4EHPGDALDH1A1SMN1; SMN2CA12
SCHEMBL27604715 0.80 KDM4E (0.52) KDM4EHPGDALDH1A1SMN1; SMN2CA12
SCHEMBL1628732 0.80 KDM4E (0.61) KDM4EHPGDALDH1A1SMN1; SMN2CA12
SCHEMBL8746650 0.79 CDC25B (0.47) KDM4EHPGDALDH1A1SMN1; SMN2CA12
SCHEMBL29220582 0.78 KDM4E (0.63) KDM4EHPGDALDH1A1SMN1; SMN2CA12
SCHEMBL9715736 0.77 HPGD (0.48) KDM4EHPGDALDH1A1SMN1; SMN2CA12
SCHEMBL3328547 0.77 ALDH1A1 (0.44) KDM4EHPGDALDH1A1SMN1; SMN2CA12
Salicylic Acid SCHEMBL10777436 0.77 ALDH1A1 (0.72) KDM4EHPGDALDH1A1SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119688859-A Exhaled breath condensate metabolite combination, kit and method for predicting invasive lung adenocarcinoma 华中科技大学同济医学院附属协和医院 2025-03-25 CN claimed
CN-117430802-B Preparation method of polyhydroxy acrylic ester macromer, method for preparing polymer polyol by using polyhydroxy acrylic ester macromer and application of polyhydroxy acrylic ester macromer 山东一诺威新材料有限公司 2024-05-10 CN claimed
CN-117801175-A Low-sensitivity ester polycarboxylate water reducer and preparation method and application thereof 科之杰新材料集团有限公司 2024-04-02 CN claimed
CN-117777375-A Ether polycarboxylate water reducer and preparation method and application thereof 科之杰新材料集团有限公司 2024-03-29 CN claimed
CN-117430802-A Preparation method of polyhydroxy acrylic ester macromer, method for preparing polymer polyol by using polyhydroxy acrylic ester macromer and application of polyhydroxy acrylic ester macromer 山东一诺威新材料有限公司 2024-01-23 CN claimed
CN-114929760-A Superabsorbent polymer and method for preparing the same 株式会社LG化学 2022-08-19 CN claimed
US-20200103401-A1 QMAX ASSAY AND APPLICATIONS (II) ESSENLIX CORPORATION (US) 2020-04-02 US claimed
EP-3166644-B1 METHOD OF SYNTHESISING ADCS USING PHOTOCLEAVABLE LINKERS ON SOLID SUPPORT ADC BIOTECHNOLOGY LTD (GB) 2019-06-19 EP claimed
WO-2018148606-A1 QMAX ASSAY AND APPLICATIONS (II) ESSENLIX CORPORATION (US) 2018-08-16 WO claimed
US-20170196990-A1 METHOD OF SYNTHESISING ADCS USING PHOTOCLEAVABLE LINKERS ON SOLID SUPPORT ADC BIOTECHNOLOGY LTD. (GB) 2017-07-13 US claimed
US-20050064798-A1 METHODS AND COMPOSITIONS FOR CHEMICAL MECHANICAL PLANARIZATION OF RUTHENIUM NOVELLUS SYSTEMS, INC. 2005-03-24 US claimed
US-6869336-B1 Methods and compositions for chemical mechanical planarization of ruthenium NOVELLUS SYSTEMS, INC. (US) 2005-03-22 US claimed
EP-0914964-B1 Positive type photosensitive composition for infrared lasers FUJI PHOTO FILM CO LTD (JP) 2004-12-29 EP claimed
EP-0909657-B1 A positive type photosensitive image-forming material for an infrared laser FUJI PHOTO FILM CO LTD (JP) 2003-06-18 EP claimed
US-6451498-B1 Photosensitive composition ATOTECH DEUTSCHLAND GMBH (DE) 2002-09-17 US claimed
EP-0623604-B1 Oxa(Thia)-diazol-oxyphenylacrylates as pesticides BAYER AG (DE) 2001-08-08 EP claimed
US-5932392-A LIGHT SENSITIVE LAYER CONTAINING A COMPOUND CAPABLE OF GENERATING AN ACID ON EXPOSURE OF INFRARED RAYS, A RESOL RESIN, AN UNSATURATED RESIN CONTAINING A MONOMER UNIT WITH A PHENOLIC HYDROXY GROUP, AND AN INFRARED ABSORBER KONICA CORPORATION (JP) 1999-08-03 US claimed
EP-0623604-A2 Oxa(Thia)-diazol-oxyphenylacrylates as pesticides BAYER AG (DE) 1994-11-09 EP claimed
US-4293626-A ORGANIC PIGMENT EASTMAN KODAK COMPANY (US) 1981-10-06 US claimed
US-4272595-A UNSATURATED NITRILE EASTMAN KODAK COMPANY (US) 1981-06-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170196990-A1 METHOD OF SYNTHESISING ADCS USING PHOTOCLEAVABLE LINKERS ON SOLID SUPPORT SBDS, ADCY8, DCK KDM4E 1246/4885HPGD 1875/4885ALDH1A1 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.